Cargando…

Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1

PURPOSE OF REVIEW: Myotonic dystrophy type 1 is a multisystemic disorder caused by a noncoding triplet repeat. The age of onset is variable across the lifespan, but in its most severe form, the symptoms appear at birth (congenital myotonic dystrophy) or in the pediatric age range (childhood-onset my...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Nicholas E., Aldana, Eugenio Zapata, Angeard, Nathalie, Ashizawa, Tetsuo, Berggren, Kiera N., Marini-Bettolo, Chiara, Duong, Tina, Ekström, Anne-Berit, Sansone, Valeria, Tian, Cuixia, Hellerstein, Leah, Campbell, Craig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814415/
https://www.ncbi.nlm.nih.gov/pubmed/31750030
http://dx.doi.org/10.1212/CPJ.0000000000000646
_version_ 1783463003147993088
author Johnson, Nicholas E.
Aldana, Eugenio Zapata
Angeard, Nathalie
Ashizawa, Tetsuo
Berggren, Kiera N.
Marini-Bettolo, Chiara
Duong, Tina
Ekström, Anne-Berit
Sansone, Valeria
Tian, Cuixia
Hellerstein, Leah
Campbell, Craig
author_facet Johnson, Nicholas E.
Aldana, Eugenio Zapata
Angeard, Nathalie
Ashizawa, Tetsuo
Berggren, Kiera N.
Marini-Bettolo, Chiara
Duong, Tina
Ekström, Anne-Berit
Sansone, Valeria
Tian, Cuixia
Hellerstein, Leah
Campbell, Craig
author_sort Johnson, Nicholas E.
collection PubMed
description PURPOSE OF REVIEW: Myotonic dystrophy type 1 is a multisystemic disorder caused by a noncoding triplet repeat. The age of onset is variable across the lifespan, but in its most severe form, the symptoms appear at birth (congenital myotonic dystrophy) or in the pediatric age range (childhood-onset myotonic dystrophy). These children have a range of disabilities that reduce the lifespan and cause significant morbidity. Currently, there are no agreed upon recommendations for caring for these children. RECENT FINDINGS: The Myotonic Dystrophy Foundation recruited 11 international clinicians who are experienced with congenital and childhood-onset myotonic dystrophy to create consensus-based care recommendations. The experts used a 2-step methodology using elements of the single text procedure and nominal group technique. Completion of this process has led to the development of clinical care recommendations for this population. SUMMARY: Children with myotonic dystrophy often require monitoring and interventions to improve the lifespan and quality of life. The resulting recommendations are intended to standardize and improve the care of children with myotonic dystrophy.
format Online
Article
Text
id pubmed-6814415
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-68144152019-11-20 Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1 Johnson, Nicholas E. Aldana, Eugenio Zapata Angeard, Nathalie Ashizawa, Tetsuo Berggren, Kiera N. Marini-Bettolo, Chiara Duong, Tina Ekström, Anne-Berit Sansone, Valeria Tian, Cuixia Hellerstein, Leah Campbell, Craig Neurol Clin Pract Review PURPOSE OF REVIEW: Myotonic dystrophy type 1 is a multisystemic disorder caused by a noncoding triplet repeat. The age of onset is variable across the lifespan, but in its most severe form, the symptoms appear at birth (congenital myotonic dystrophy) or in the pediatric age range (childhood-onset myotonic dystrophy). These children have a range of disabilities that reduce the lifespan and cause significant morbidity. Currently, there are no agreed upon recommendations for caring for these children. RECENT FINDINGS: The Myotonic Dystrophy Foundation recruited 11 international clinicians who are experienced with congenital and childhood-onset myotonic dystrophy to create consensus-based care recommendations. The experts used a 2-step methodology using elements of the single text procedure and nominal group technique. Completion of this process has led to the development of clinical care recommendations for this population. SUMMARY: Children with myotonic dystrophy often require monitoring and interventions to improve the lifespan and quality of life. The resulting recommendations are intended to standardize and improve the care of children with myotonic dystrophy. Lippincott Williams & Wilkins 2019-10 /pmc/articles/PMC6814415/ /pubmed/31750030 http://dx.doi.org/10.1212/CPJ.0000000000000646 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Review
Johnson, Nicholas E.
Aldana, Eugenio Zapata
Angeard, Nathalie
Ashizawa, Tetsuo
Berggren, Kiera N.
Marini-Bettolo, Chiara
Duong, Tina
Ekström, Anne-Berit
Sansone, Valeria
Tian, Cuixia
Hellerstein, Leah
Campbell, Craig
Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1
title Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1
title_full Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1
title_fullStr Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1
title_full_unstemmed Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1
title_short Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1
title_sort consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814415/
https://www.ncbi.nlm.nih.gov/pubmed/31750030
http://dx.doi.org/10.1212/CPJ.0000000000000646
work_keys_str_mv AT johnsonnicholase consensusbasedcarerecommendationsforcongenitalandchildhoodonsetmyotonicdystrophytype1
AT aldanaeugeniozapata consensusbasedcarerecommendationsforcongenitalandchildhoodonsetmyotonicdystrophytype1
AT angeardnathalie consensusbasedcarerecommendationsforcongenitalandchildhoodonsetmyotonicdystrophytype1
AT ashizawatetsuo consensusbasedcarerecommendationsforcongenitalandchildhoodonsetmyotonicdystrophytype1
AT berggrenkieran consensusbasedcarerecommendationsforcongenitalandchildhoodonsetmyotonicdystrophytype1
AT marinibettolochiara consensusbasedcarerecommendationsforcongenitalandchildhoodonsetmyotonicdystrophytype1
AT duongtina consensusbasedcarerecommendationsforcongenitalandchildhoodonsetmyotonicdystrophytype1
AT ekstromanneberit consensusbasedcarerecommendationsforcongenitalandchildhoodonsetmyotonicdystrophytype1
AT sansonevaleria consensusbasedcarerecommendationsforcongenitalandchildhoodonsetmyotonicdystrophytype1
AT tiancuixia consensusbasedcarerecommendationsforcongenitalandchildhoodonsetmyotonicdystrophytype1
AT hellersteinleah consensusbasedcarerecommendationsforcongenitalandchildhoodonsetmyotonicdystrophytype1
AT campbellcraig consensusbasedcarerecommendationsforcongenitalandchildhoodonsetmyotonicdystrophytype1